Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tilray Brands, Inc. - Common Stock (NQ:TLRY)

0.6514 -0.0028 (-0.43%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tilray Brands, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
2 Beaten-Down Stocks Near Their 52-Week Lows That Aren't Worth Buying
Via The Motley Fool
This Week In Cannabis: Earnings, Europe's Buzzing Scene, The UN And More
Cannabis news this week: California extends hemp ban, UN schedules HHC, major earnings reports & Tilray expands. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bearish Sentiment Across The Cannabis Space - Check Full Movers For March 13, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Activist Says White House Called for Federal Cannabis Legalization Proposal
Via Investor Brand Network
Topics Cannabis Government
Exposures Cannabis Political
Looking Into Tilray Brands's Recent Short Interest
Via Benzinga
Looking Into Tilray Brands's Recent Short Interest
Via Benzinga
Activist Says White House Called for Federal Cannabis Legalization Proposal
Via CannabisNewsWire
Topics Cannabis Government
Exposures Cannabis Political
What's Going On With Cannabis Firm Tilray Brands Stock On Wednesday?
Tilray Brands' stock rises following the expansion of its non-alcoholic craft beer brand and the launch of a new medical cannabis product. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Tilray Grows Its Non-Alcoholic Craft Beer Line, Runner's High Brewing, Across the East Coast and Mid-West Regions
Runner’s High Connects with Social Running Communities and Caters to Lifestyle Preferences with its Low-Calorie Brews 
From Tilray Brands, Inc.
Via GlobeNewswire
Bullish Sentiment Across The Cannabis Space - Check Full Movers For March 11, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
2 Beaten-Down Stocks to Avoid
Via The Motley Fool
Tilray Medical Launches Tilray Craft: Introducing High THC, High Terpene Genetics to the German Medical Cannabis Market
From Tilray Brands, Inc.
Via GlobeNewswire
Cannabis Stock Movers For March 10, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Blue Point Brewing Co. Introduces Long Island Light: A Premium Craft Lager
Blue Point’s New Long Island Light Premium Lager Contains Only 90 Calories, Ideal for Low-Calorie Beer Fans 
From Tilray Brands, Inc.
Via GlobeNewswire
The Canadian Cannabis Report - Monday, March 3
The past, present and future of the Canadian cannabis sector. 
Via Talk Markets
Topics Cannabis Stocks / Equities
Exposures Cannabis
1 Growth Stock with All-Star Potential and 2 to Ignore
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s... 
Via StockStory
Exposures COVID-19
Germany's Cannabis Imports Increase 4x In 2024 Amid Regulatory Changes: Which Countries Are Top Providers?
Germany's medical cannabis imports surged 4X in Q4 2024, driven by new laws. Canada & Portugal lead supply. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Tilray (TLRY): Buy, Sell, or Hold Post Q4 Earnings?
Shareholders of Tilray would probably like to forget the past six months even happened. The stock dropped 54.1% and now trades at $0.87. This was partly driven by its softer quarterly results and may... 
Via StockStory
Topics Cannabis
Exposures Cannabis
Tilray Brands Announces 420 Concert with Multi-Platinum Artist Don Toliver
Celebrate 420 with Tilray’s Leading Cannabis Brands and Nationwide Activations Across Canada 
From Tilray Brands, Inc.
Via GlobeNewswire
Testing Lab Fraud Could Be Addressed by Involving Marijuana Industry Actors
Via Investor Brand Network
Topics Cannabis Fraud
Exposures Cannabis Legal
Testing Lab Fraud Could Be Addressed by Involving Marijuana Industry Actors
Via CannabisNewsWire
Topics Cannabis Fraud
Exposures Cannabis Legal
Good Supply Introduces New Monsters Resin Vapes: Full Spectrum Highs
Good Supply Expands Product Lineup with 1.5g and 2g Vapes 
From Tilray Brands, Inc.
Via GlobeNewswire
This Week In Cannabis: RFK's HHS Confirmation, Trump's DEA Bombshell, Earnings, Global News And More
Kennedy's HHS appointment, Trump's DEA pick, new fast-track meds, and global cannabis trends—this week reshapes the future of cannabis. 
Via Benzinga
Topics Cannabis Government
Exposures Cannabis Political
420 with CNW — The US is Awash with Black Market Marijuana
Via CannabisNewsWire
Topics Cannabis Law Enforcement
Exposures Cannabis Legal
Tilray Expands Medical Cannabis Portfolio in Germany
Global Leader in Medical Cannabis Launches New Cannabis Extract Products and Formulations 
From Tilray Brands, Inc.
Via GlobeNewswire
Blue Point Brewing Announces 5th Annual Shakedown on Main Street Festival
Blue Point Hosts Epic Summer Kickoff with Performances by Ripe, Badfish, Dogs in a Pile, and Ernie & the Band! 
From Tilray Brands, Inc.
Via GlobeNewswire
Monday's session: most active stocks
Let's dive into the action on the US markets on Monday. Here are the most active stocks that are driving the market today. 
Via Chartmill
Tilray Brands Enhances Global Cannabis Supply Chain
Tilray Increases Industry-Leading Capacity to Meet Global Demand, Driving Growth Across Canada and Europe 
From Tilray Brands, Inc.
Via GlobeNewswire
3 Beaten-Down Stocks That Aren't Worth Buying on the Dip
Via The Motley Fool
This Week In Cannabis: DeSantis' Anti-Weed Push, NY's Drug Decriminalization, Aurora's Record Earnings, Tilray And More Global News
Cannabis news: DeSantis fights Florida's 2026 ballot, US cannabis growth slows, Tilray lands a JetBlue deal, Aurora reports stellar earnings and more. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.